-
Mashup Score: 1Allo or auto CAR-T cells for refractory BCP-ALL? - 1 year(s) ago
Autologous CD19-chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment of pediatric relapsed/refractory B-cell precursor acute lymphobl
Source: American Society of HematologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170 - 1 year(s) ago
Key Points. Pembrolizumab monotherapy provides sustained antitumor activity in heavily pretreated R/R PMBCL.Complete responses were maintained after ∼4 years of
Source: American Society of HematologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Pembrolizumab in PMBCL: can it go the distance? - 1 year(s) ago
In this issue of Blood, Zinzani et al present long-term follow-up data demonstrating that pembrolizumab, an inhibitor of programmed cell death protein 1 (PD-1),
Source: American Society of HematologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Natural history and rate of progression of retinopathy in adult patients with sickle cell disease: an 11-year follow-up study - 1 year(s) ago
Key Points. Adult patients with SCD showed significant progression of SCR during follow-up.Differentiated strategies for screening and follow-up of retinopathy
Source: American Society of HematologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Key Points. Mice with a truncating mutation in GATA1 have lifelong anemia that is, in part, due to altered erythroid progenitor populations.Gata1s mutant mouse
Source: American Society of HematologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantation - 1 year(s) ago
Key Points. CAST regimen is safe and effective in reducing acute GVHD after haploidentical peripheral blood transplantation.Our outcomes provide an impetus to f
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma - 1 year(s) ago
Key Points. Whole genome sequencing of 36 Hodgkin lymphoma (HL) families identifies 33 coding and 11 noncoding HL-risk variants.Recurrent damaging variants are
Source: American Society of HematologyCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0Unraveling family ties in Hodgkin lymphoma - 1 year(s) ago
In this issue of Blood, Flerlage et al1 expand our understanding of genetic factors which contribute to a predisposition to the development of Hodgkin lymphoma
Source: American Society of HematologyCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0Specific subtype distribution with impact on prognosis of TP53 single-hit and double-hit events in AML and MDS - 1 year(s) ago
TO THE EDITOR:
Source: American Society of HematologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Real-world results of CAR-T cell therapy for large B-cell lymphoma with CNS involvement: a GLA/DRST study - 1 year(s) ago
Francis Ayuketang Ayuk, Nico Gagelmann, Bastian von Tresckow, Gerald Georg Wulf, Kai Rejeski, Matthias Stelljes, Olaf Penack, Claudia D Baldus, Nicolaus Kröger,
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
Allo or auto CAR-T cells for refractory BCP-ALL? https://t.co/aYg37mXDC1